Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Biogen inc. crawled time : 12:00 save search
EISAI TO PRESENT DATA ON ROBUST NEUROLOGY PORTFOLIO AT THE 76th AMERICAN ACADEMY OF NEUROLOGY® (AAN) ANNUAL MEETING
Published: 2024-04-12 (Crawled : 12:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.03%
H: 0.49%
C: -2.96%
neurology meeting
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Published: 2024-04-02 (Crawled : 12:00) - globenewswire.com
AVTX | $11.71 -2.5% -2.56% 68K
|
Manufacturing
|
| O: -22.8%
H: 15.52%
C: 1.07%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: -2.95%
H: 0.0%
C: -1.43%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -1.11%
H: 0.16%
C: -2.56%
biotech leaders therapeutics
Dyne Therapeutics Announces CEO Transition
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
DYN | $23.89 1.02% 1.0% 970K
|
Health Technology
|
| O: -13.24%
H: 11.02%
C: 6.37%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.15%
H: 0.23%
C: -0.5%
ceo therapeutics
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Published: 2024-02-23 (Crawled : 12:00) - globenewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.25%
H: 2.95%
C: 2.88%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.43%
H: 1.06%
C: -0.05%
qalsody first chmp genetic positive treat therapy
ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.
Published: 2023-12-14 (Crawled : 12:00) - globenewswire.com
SAGE | $13.35 2.42% 2.36% 1.3M
|
Health Technology
|
| O: 3.04%
H: 0.0%
C: -3.59%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.56%
H: 1.74%
C: -0.18%
depression treatment women
Biogen to Present New Data at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Meeting
Published: 2023-10-19 (Crawled : 12:00) - globenewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.33%
disease alzheimer’s trials meeting
Biogen Appoints Jane Grogan as Head of Research
Published: 2023-09-06 (Crawled : 12:00) - globenewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: -1.03%
research
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Published: 2023-08-07 (Crawled : 12:00) - biospace.com/
SAGE | $13.35 2.42% 2.36% 1.3M
|
Health Technology
|
| O: -46.84%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -2.22%
H: 3.34%
C: 3.14%
business pipeline therapeutics financial results
Alcyone Therapeutics Receives FDA IDE Approval to Initiate Clinical Study of the ThecaFlex DRxTM System for Administration of SPINRAZA® (nusinersen)
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.08%
H: 1.3%
C: 0.59%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.12%
H: 0.56%
C: 0.37%
spinraza fda approval system therapeutics study
BiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directors
Published: 2023-05-12 (Crawled : 12:00) - globenewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.37%
H: 0.61%
C: -1.34%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.17%
H: 0.3%
C: -0.05%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.14%
C: -0.44%
AMRN | News | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: 1.69%
H: 3.33%
C: 2.5%
PHGE | $0.2852 -3.58% 3.16% 69K
|
Health Technology
|
| O: 18.25%
H: 0.0%
C: -7.0%
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
Published: 2023-04-10 (Crawled : 12:00) - biospace.com/
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 2.21%
C: -3.98%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: -0.91%
H: 0.38%
C: -4.84%
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: -1.01%
H: 0.29%
C: -3.21%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.49%
H: 0.09%
C: -0.89%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: -2.16%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: -2.05%
therapeutics
Sage Therapeutics and Biogen Share Update on FDA Advisory Committee for Zuranolone
Published: 2023-03-08 (Crawled : 12:00) - biospace.com/
SAGE | $13.35 2.42% 2.36% 1.3M
|
Health Technology
|
| O: 1.84%
H: 7.06%
C: 7.04%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.35%
C: -0.7%
fda therapeutics update
Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published: 2023-02-06 (Crawled : 12:00) - globenewswire.com
SAGE | $13.35 2.42% 2.36% 1.3M
|
Health Technology
|
| O: 0.27%
H: 6.75%
C: 3.25%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.51%
H: 2.52%
C: 1.12%
treatment fda drug application grants therapeutics review depression major depressive disorder
Parkinson's Disease Drugs Market to Reach $10.4 Bn, Globally, by 2031 at 6.2% CAGR: Allied Market Research
Published: 2022-11-17 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -1.62%
H: 1.01%
C: 0.55%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.56%
H: 1.64%
C: 1.47%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -2.04%
H: 1.21%
C: 1.09%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.59%
H: 1.39%
C: 0.79%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.98%
H: 1.97%
C: 1.68%
research disease parkinson's market
Alkermes plc Reports Third Quarter 2022 Financial Results
Published: 2022-11-02 (Crawled : 12:00) - investor.alkermes.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.05%
H: 2.57%
C: -0.65%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: 2.15%
H: 5.18%
C: 1.31%
financial results
Digital Biomarkers Market Size to be Worth $13,966.16 Million by 2030: Grand View Research, Inc.
Published: 2022-11-01 (Crawled : 12:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.0%
H: 1.19%
C: -1.2%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.28%
H: 1.21%
C: 0.91%
biomarkers market
Biogen Announces FDA’s 3-Month Extension of Review Period for the New Drug Application for Tofersen
Published: 2022-10-17 (Crawled : 12:00) - globenewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.97%
H: 1.62%
C: -0.62%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.54%
H: 2.99%
C: 1.32%
drug extension application review
Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone
Published: 2022-09-19 (Crawled : 12:00) - biospace.com/
SAGE | $13.35 2.42% 2.36% 1.3M
|
Health Technology
|
| O: 0.0%
H: 4.41%
C: 3.82%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.66%
H: 1.6%
C: 1.15%
therapeutics
FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS
Published: 2022-07-26 (Crawled : 12:00) - globenewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 1.96%
H: 0.2%
C: -2.61%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.42%
H: 3.54%
C: 2.01%
fda drug genetic als application grants review
Idiopathic Pulmonary Fibrosis Market Size to hit USD 5326.8 Million in 2028 | Growing at 7.1 % CAGR, Says Brandessence Market Research
Published: 2022-06-03 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.4%
H: 4.05%
C: -1.35%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 0.29%
H: 2.68%
C: 2.39%
FGEN | $1.15 -1.71% -1.74% 1.3M
|
Health Technology
|
| O: 1.57%
H: 2.99%
C: 2.99%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.16%
H: 3.3%
C: 1.27%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
fibrosis research growing market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.